search
Back to results

Efficacy of Strategies Involving Self-sampling to Reach Women Not Participating in Regular Cervical Cancer Screening (CapU4)

Primary Purpose

Cancer Screening Test

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
self-sampling
Sponsored by
Centre Regional de Coordination des Depistages des Cancer - Pays de la Loire
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Cancer Screening Test focused on measuring cervical cancer, screening coverage, cancer screening test, under-screened women, urinary self-sampling, vaginal self-sampling, randomised controlled trial, semi-structured interviews

Eligibility Criteria

30 Years - 65 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • women aged between 30 and 65 years
  • living in the Departments of Mayenne and Sarthe (Pays de la Loire, France)
  • who have not carried out a screening test (cytology of smear or HPV test) following a letter sent 12 months previously in 2020.

Exclusion Criteria:

  • recent cervical sampling (less than three years old)
  • women younger than 30 or older than 65 years
  • women who have had a hysterectomy
  • women with ongoing follow-up for a cervical lesion
  • women who are not members or beneficiaries of a social security system.

Sites / Locations

  • CRCDC Pays de la LoireRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

No Intervention

Experimental

Experimental

Arm Label

control

vaginal self-sampling

urinary self-sampling

Arm Description

The control arm corresponds to women receive a conventional invitation letter sent by post to the home address of eligible women recommending them to make an appointment to a doctor or a midwife for the collection of a cervical specimen.

eligible women receive at their home address a vaginal self-sampling kit in addition to the conventional invitation letter

eligible women receive at their home address a urine collection kit in addition to the conventional invitation letter

Outcomes

Primary Outcome Measures

Rate of participation in each arm (%)
(number of responding / number of invited)

Secondary Outcome Measures

Rate of participation (%)
(number of responding / number of invited). Contrast in participation between the 2 experimental arms
Rate of participation (%) with questionnaire or not
(number of responding / number of invited). Contrast in participation between women that received a questionnaire or not
Rate of screen test positivity (%)
Virological result. presence of high-risk HPV
Percentage of women screened positive with adherence to gynecological follow-up
gynecological follow-up (cytological results)
Impact of age on the participation (rate of participation %)
age
Impact of age on the adherence to gynecological follow-up (% of women)
age
Impact of reimbursement status on the participation (rate of participation %)
reimbursement status (benefit or not from supplementary universal health care coverage)
Impact of reimbursement status on the adherence to gynecological follow-up (% of women)
reimbursement status (benefit or not from supplementary universal health care coverage)
Impact of geographical area on the participation (rate of participation %)
geographical area (including the deprivation index corresponding with the statistical sector where the woman is domiciled)
Impact of geographical area on the adherence to gynecological follow-up (% of women)
geographical area (geographical area (including the deprivation index corresponding with the statistical sector where the woman is domiciled)
Obstacles and levers emerging from the speech of the women participating in the research (thematic analysis)
thematic analysis integrating a specific focus on the indicators identified in previous studies (e.g. lack of time, discomfort with regard to the location or bad experience encountered during another type of examination, etc.).
Obstacles and levers emerging from the speech of the women participating in the research (categorical analysis)
categorical analysis based on Linguistic Inquiry and Word count which allows, among other things, to automatically categorise positive or negative emotions related to themes for example associated with the disease or beliefs
Obstacles and levers emerging from the speech of the health professionals participating in the research (thematic analysis)
thematic analysis integrating a specific focus on the indicators identified in previous studies (e.g. lack of time, discomfort with regard to the location or bad experience encountered during another type of examination, etc.).
Obstacles and levers emerging from the speech of the health professionals participating in the research (categorical analysis)
categorical analysis based on Linguistic Inquiry and Word count which allows, among other things, to automatically categorise positive or negative emotions related to themes for example associated with the disease or beliefs

Full Information

First Posted
January 26, 2022
Last Updated
March 17, 2023
Sponsor
Centre Regional de Coordination des Depistages des Cancer - Pays de la Loire
Collaborators
National Cancer Institute, France, Sciensano, University Hospital, Angers, University of Angers
search

1. Study Identification

Unique Protocol Identification Number
NCT05243888
Brief Title
Efficacy of Strategies Involving Self-sampling to Reach Women Not Participating in Regular Cervical Cancer Screening
Acronym
CapU4
Official Title
A Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-sampling to Reach Women Not Participating in Regular Cervical Cancer Screening
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 9, 2022 (Actual)
Primary Completion Date
September 2023 (Anticipated)
Study Completion Date
February 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Regional de Coordination des Depistages des Cancer - Pays de la Loire
Collaborators
National Cancer Institute, France, Sciensano, University Hospital, Angers, University of Angers

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The cervical cancer screening coverage remains moderate (60%) in France. The aim of the study is to evaluate the efficacy of two experimental invitation strategies (offer of urine or vaginal self-sampling kits) to reach under-screened populations and compare them with the current invitation strategy in rural departments (low medical density and low participation rate) in France. The study is a randomised controlled trial with three arms: a control arm (conventional invitation letter) and two experimental arms (mailing of a urine or vaginal self-sampling kit). The target population includes women aged 30-65 years, who had no screening test recorded since more than four years and who did not respond to an invitation letter within twelve months before. The primary outcome measure is the participation rate in each arm. A team of psychologists will also investigate attitudes and experiences by semi-structured/focus-group interviews with voluntary CapU4 participants and with health professionals. CapU4 will identify effective strategies to reach women not responding to current screening invitations and will generate information about acceptance of self-sampling among women and health professionals.
Detailed Description
Research question: does the offer of self-sampling kits result in higher attendance to cervical cancer screening compared to sending invitation letters which recommend women to contact a health professional for taking a cervical specimen? Systematic reviews indicate that Human Papillomavirus (HPV) testing on vaginal specimens taken by the woman her-self is as accurate to detect cervical precancer as HPV testing of cervical specimens collected by a clinician, under the condition that a validated polymerase chain reaction (PCR)-based HPV assay is used. Similar results are shown from recent studies where HPV testing was performed on first-void urine collected with an appropriate device and transport medium. A recent meta-analysis of randomised trials showed higher response rates when under-screened women receive a self-sampling kit at home compared to traditional invitation or reminder letters. However, the absolute participation rates are highly variable among studies. Whereas qualitative research indicates that women prefer collection of urine rather than a vaginal self-sample, no data are available that the offer of urine kits would result in higher participation among women who do not participate regularly in cervical cancer screening. Objectives: To evaluate the effectiveness of two experimental invitation strategies (urine or vaginal self-sampling) to reach under-screened populations and compare them to the current invitation strategy in rural departments in France. To improve the response rate among women aged 30 to 65 years (not screened over a period longer than the recommended screening interval) who did not respond to a conventional prior invitation. Trial design: 1:1:1 randomised population-based participation trial, with 2 experimental and 1 control arm, with in each arm a 1:1 sub-randomisation with subgroup A receiving a questionnaire and subgroup B receiving no questionnaire.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cancer Screening Test
Keywords
cervical cancer, screening coverage, cancer screening test, under-screened women, urinary self-sampling, vaginal self-sampling, randomised controlled trial, semi-structured interviews

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The study is a randomised controlled trial with three arms: a control arm (conventional invitation letter) and two experimental arms (mailing of a urine or vaginal self-sampling kit).
Masking
None (Open Label)
Allocation
Randomized
Enrollment
15000 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
control
Arm Type
No Intervention
Arm Description
The control arm corresponds to women receive a conventional invitation letter sent by post to the home address of eligible women recommending them to make an appointment to a doctor or a midwife for the collection of a cervical specimen.
Arm Title
vaginal self-sampling
Arm Type
Experimental
Arm Description
eligible women receive at their home address a vaginal self-sampling kit in addition to the conventional invitation letter
Arm Title
urinary self-sampling
Arm Type
Experimental
Arm Description
eligible women receive at their home address a urine collection kit in addition to the conventional invitation letter
Intervention Type
Diagnostic Test
Intervention Name(s)
self-sampling
Intervention Description
eligible women receive at their home address a self-sampling kit in addition to the conventional invitation letter
Primary Outcome Measure Information:
Title
Rate of participation in each arm (%)
Description
(number of responding / number of invited)
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Rate of participation (%)
Description
(number of responding / number of invited). Contrast in participation between the 2 experimental arms
Time Frame
6 months
Title
Rate of participation (%) with questionnaire or not
Description
(number of responding / number of invited). Contrast in participation between women that received a questionnaire or not
Time Frame
6 months
Title
Rate of screen test positivity (%)
Description
Virological result. presence of high-risk HPV
Time Frame
24 months
Title
Percentage of women screened positive with adherence to gynecological follow-up
Description
gynecological follow-up (cytological results)
Time Frame
24 months
Title
Impact of age on the participation (rate of participation %)
Description
age
Time Frame
6 months
Title
Impact of age on the adherence to gynecological follow-up (% of women)
Description
age
Time Frame
24 months
Title
Impact of reimbursement status on the participation (rate of participation %)
Description
reimbursement status (benefit or not from supplementary universal health care coverage)
Time Frame
6 months
Title
Impact of reimbursement status on the adherence to gynecological follow-up (% of women)
Description
reimbursement status (benefit or not from supplementary universal health care coverage)
Time Frame
24 months
Title
Impact of geographical area on the participation (rate of participation %)
Description
geographical area (including the deprivation index corresponding with the statistical sector where the woman is domiciled)
Time Frame
6 months
Title
Impact of geographical area on the adherence to gynecological follow-up (% of women)
Description
geographical area (geographical area (including the deprivation index corresponding with the statistical sector where the woman is domiciled)
Time Frame
24 months
Title
Obstacles and levers emerging from the speech of the women participating in the research (thematic analysis)
Description
thematic analysis integrating a specific focus on the indicators identified in previous studies (e.g. lack of time, discomfort with regard to the location or bad experience encountered during another type of examination, etc.).
Time Frame
24 months
Title
Obstacles and levers emerging from the speech of the women participating in the research (categorical analysis)
Description
categorical analysis based on Linguistic Inquiry and Word count which allows, among other things, to automatically categorise positive or negative emotions related to themes for example associated with the disease or beliefs
Time Frame
24 months
Title
Obstacles and levers emerging from the speech of the health professionals participating in the research (thematic analysis)
Description
thematic analysis integrating a specific focus on the indicators identified in previous studies (e.g. lack of time, discomfort with regard to the location or bad experience encountered during another type of examination, etc.).
Time Frame
24 months
Title
Obstacles and levers emerging from the speech of the health professionals participating in the research (categorical analysis)
Description
categorical analysis based on Linguistic Inquiry and Word count which allows, among other things, to automatically categorise positive or negative emotions related to themes for example associated with the disease or beliefs
Time Frame
24 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: women aged between 30 and 65 years living in the Departments of Mayenne, Vendée and Sarthe (Pays de la Loire, France) who have not carried out a screening test (cytology of smear or HPV test) following a letter sent 12 months previously (in 2020 or 2021). Exclusion Criteria: recent cervical sampling (less than three years old) women younger than 30 or older than 65 years women who have had a hysterectomy women with ongoing follow-up for a cervical lesion women who are not members or beneficiaries of a social security system.
Facility Information:
Facility Name
CRCDC Pays de la Loire
City
Angers
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anne-Sophie Banaszuk, MD
Phone
+33 2 41 05 06 67
Email
as.banaszuk@depistagecancers.fr

12. IPD Sharing Statement

Learn more about this trial

Efficacy of Strategies Involving Self-sampling to Reach Women Not Participating in Regular Cervical Cancer Screening

We'll reach out to this number within 24 hrs